Health
Elon Musk says expects Neuralink to begin human trials in si
November 30, 2022
Our Latest News In:
health
health
Health
Roche shutters most trials of Alzheimer's drug after failed
November 30, 2022
Health
REUTERS NEXT: Hunger-struck Africa needs liquidity, debt rel
November 30, 2022
Health
Indonesia central bank says monetary policy to remain pro-st
November 30, 2022
Health
The Caregiver's Lament: How to handle the costs of care
November 29, 2022
Health
Snap employees to work from office starting February
November 28, 2022
Health
Rare China protests roil global commodities markets
November 28, 2022
Health
Banker with cancer claims $5 million from NatWest for unfair
November 28, 2022
Health
Apple Inc supplier Foxconn's China plant hit by fresh worker
November 22, 2022
Health
China's top auto association cancels Shanghai event citing C
November 22, 2022
Health
Factbox-Pharmacies, drug companies settle lawsuits over U.S.
November 22, 2022
Health
Teva, AbbVie finalize $6.6 billion U.S. opioid settlements
November 22, 2022
Health
Gavi says it is not in breach of Novavax vaccine deal
November 22, 2022
Health
Analysis-China's great reopening may come too late for many
November 21, 2022
Health
Analysis-U.S. midterms dampen Big Pharma hopes for drug pric
November 18, 2022
Health
Tyson Foods ends COVID-19 vaccine mandate for employees
November 16, 2022
DJIA SNAPSHOT
* Market data is delayed
MARKET INFORMATION
| LAST | CHG | %CHG | |
| DJIA | 34,326.00 | -18 | 0 %  |
| NASDAQ | 322.50 | -1 | 0 % |
| S&P 500 | 0.00 | +0 | 0 % |
| OIL | 3,020.00 | +0 | 0 % |
|
WE PROFILE LOTS OF AMAZING STOCKS
Our job and our
passion is sharing awesome companies that can be overlooked by wallstreet. We love
finding the diamonds in the rough that could turn into the next big mover in the
markets and we enjoy sharing ideas in our Investor Alley with picks like these:
|
The content on this site is not a solicitation to buy or sell securities and should be regarded as "entertainment use only". Each content provider featured on DearWallstreet.com has their own opinion and bias and may not share similar views as DearWallstreet.com. DearWallstreet.com is not a registered financial advisor, or registered financial advisory firm. Any statement or opinion presented on DearWallstreet.com should be considered "as is" without warranties of any kind either expressed or implied, and should NOT be considered investment advice. By using this site, you agree to the terms presented in our Full Disclosure & Disclaimer Page.
© 2022 Dear Wallstreet.com | 11138 Del Amo Blvd. #359 Lakewood, CA 90715
